IMDEVIMAB
UNII 2Z3DQD2JHM

Substance Identification & Data

This profile provides standardized clinical and technical data for Imdevimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2Z3DQD2JHM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2415933-40-1 and the RxNorm Concept ID (RxCUI) 2465249. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2Z3DQD2JHM

CAS Registry Number

2415933-40-1

RxNorm Concept ID

2465249

Detailed Substance Profile

Preferred Name

IMDEVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C177063

National Cancer Institute reference terminology for clinical and research data.

INN ID

11863

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-238

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Imdevimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IMDEVIMAB

Common Names & Synonyms

IMDEVIMAB [INN]

IMDEVIMAB [JAN]

IMDEVIMAB [USAN]

IMDEVIMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL REGN10987 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN10987 .LAMBDA.-CHAIN, DIMER

Technical Codes

REGN10987

REGN-10987

External Clinical & Regulatory Resources

Previous UNII2Z3A32JUA6

Next UNII2Z3E1OF81V